These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 91538)

  • 41. Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin.
    Alpha B; Cox L; Crowther N; Clark PM; Hales CN
    Eur J Clin Chem Clin Biochem; 1992 Jan; 30(1):27-32. PubMed ID: 1576236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay.
    Starr JI; Mako ME; Juhn D; Rubenstein AH
    J Lab Clin Med; 1978 Apr; 91(4):683-92. PubMed ID: 641392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A rapid, sensitive and versatile two-site immunoradiometric assay for insulin.
    Guest PC; Lowing C; Arden SD; Gray IP; Hutton JC
    Mol Cell Endocrinol; 1989 Dec; 67(2-3):173-8. PubMed ID: 2693160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis.
    Hamdi I; Green M; Shneerson JM; Palmer CR; Hales CN
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):21-6. PubMed ID: 8348704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum.
    Bowsher RR; Wolny JD; Frank BH
    Diabetes; 1992 Sep; 41(9):1084-90. PubMed ID: 1499862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of circulating insulin and proinsulin in man.
    Horwitz DL; Rubenstein AH
    Isr J Med Sci; 1974 Oct; 10(10):1201-11. PubMed ID: 4373412
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin deficiency in non-insulin-dependent diabetes.
    Temple RC; Carrington CA; Luzio SD; Owens DR; Schneider AE; Sobey WJ; Hales CN
    Lancet; 1989 Feb; 1(8633):293-5. PubMed ID: 2563455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG
    Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL; Jacobson RK; Porte D; Kahn SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoradiometric assay of human proinsulin and partially processed proinsulin with use of monoclonal antibody and streptavidin-biotin labeling.
    Kim JQ; Cho HI; Kim SI; Lee HK; Hales CN
    J Korean Med Sci; 1989 Dec; 4(4):171-7. PubMed ID: 2639693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbohydrate metabolism in pregnancy: XIII. Relationships between plasma insulin and proinsulin during late pregnancy in normal and diabetic subjects.
    Phelps RL; Bergenstal R; Freinkel N; Rubenstein AH; Metzger BE; Mako M
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1085-91. PubMed ID: 1107346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus.
    Deacon CF; Schleser-Mohr S; Ballmann M; Willms B; Conlon JM; Creutzfeldt W
    Acta Endocrinol (Copenh); 1988 Dec; 119(4):549-54. PubMed ID: 3059740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metabolism of insulin and immunoreactive insulin-like substances (proinsulin, HWIRI) in vivo in man].
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1982; 43(1):15-21. PubMed ID: 6291446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of serum C-peptide immunoreactivity by radioimmunoassay in insulin-dependent diabetics.
    Kumar MS; Schumacher OP; Deodhar SD
    Am J Clin Pathol; 1980 Jul; 74(1):78-82. PubMed ID: 6994486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
    Hartling SG; Garne S; Binder C; Heilmann C; Petersen W; Petersen KE; Koch C
    Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hypoglycemia: clarification and etiology].
    Keller U
    Schweiz Med Wochenschr; 1980 Mar; 110(13):495-8. PubMed ID: 6246574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin and proinsulin in normal and chemical diabetic children.
    Burghen GA; Etteldorf JN; Trouy RL; Kitabchi AE
    J Pediatr; 1976 Jul; 89(1):48-53. PubMed ID: 932902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The diagnosis of fasting hypoglycemia due to an islet-cell tumor obscured by a highly specific insulin assay.
    Chia CW; Saudek CD
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1464-7. PubMed ID: 12679423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypersecretion of proinsulin in thyrotoxicosis.
    Sestoft L; Heding LG
    Diabetologia; 1981 Aug; 21(2):103-7. PubMed ID: 7021283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers.
    Wang PW; Abbasi F; Carantoni M; Chen YD; Azhar S; Reaven GM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3221-4. PubMed ID: 9329342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.